Back to mobile site

Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc

October 17, 2018 4:01 PM EDT Send to a Friend
Krystal Biotech, Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login